Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials.

Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark.
The American Journal of Gastroenterology (Impact Factor: 9.21). 01/2008; 102(12):2842-8; quiz 2841, 2849. DOI: 10.1111/j.1572-0241.2007.01564.x
Source: PubMed

ABSTRACT To compare banding ligation versus beta-blockers as primary prophylaxis in patients with esophageal varices and no previous bleeding.
Randomized trials were identified through electronic databases, reference lists in relevant articles, and correspondence with experts. Three authors extracted data. Random effects meta-analysis and metaregression were performed. The reported allocation sequence generation and concealment were extracted as measures of bias control.
The initial searches identified 1,174 references. Sixteen trials were included. In 15 trials, patients had high-risk varices. Three trials reported adequate bias control. All trials reported mortality for banding ligation (116/573 patients) and beta-blockers (115/594 patients). Mortality in the two treatment groups was not significantly different in the trials with adequate bias control (relative risk 1.22, 95% CI 0.84-1.78) or unclear bias control (RR 1.02, 95% CI 0.75-1.39). Trials with adequate bias control found no significant difference in bleeding rates (RR 0.86, 95% CI 0.55-1.35). Trials with unclear bias control found that banding ligation significantly reduced bleeding (RR 0.56, 95% CI 0.41-0.77). Both treatments were associated with adverse events. In metaregression analyses, the estimated effect of ligation was significantly more positive if trials were published as abstracts. Likewise, the shorter the follow-up, the more positive the estimated effect of ligation.
Banding ligation and beta-blockers may be used as primary prophylaxis in high-risk esophageal varices. The estimated effect of banding ligation in some trials may be biased and was associated with the duration of follow-up. Further high-quality trials are still needed.

Download full-text


Available from: Christian Gluud, Mar 12, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The development and subsequent clinical application of the beta-adrenergic receptor blocking drugs over the past 50 years represent one of the major advances in human pharmacotherapy. No other class of synthetic drugs has demonstrated such widespread therapeutic utility for the treatment of so many cardiovascular and noncardiovascular diseases. In addition, these drugs have proven to be molecular probes that have contributed to our understanding of disease, and on the molecular level, both the structure and the function of the 7 transmembrane G protein receptors, which mediate the actions of many different hormones, neurotransmitters, and drugs. The evolution of beta-blocker drug development has led to refinements in their pharmacodynamic actions that include agents with relative beta1-selectivity, partial agonist activity, concomitant alpha-adrenergic blockers activity, and direct vasodilator activity. In addition, long-acting and ultra-short-acting formulations of beta-blockers have also demonstrated a remarkable record of clinical safety in patients of all ages. Indeed, the beta-adrenergic blockers have provided us with a great clinical legacy for now and in years to come.
    American journal of therapeutics 15(6):565-76. · 1.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute variceal hemorrhage is a medical emergency. Approximately 40% of patients with cirrhosis are found to have esophageal varices on endoscopic evaluation (Bosch et al.2003), and approximately one third of patients will experience variceal hemorrhage (Kleber et al. 1991; The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices 1988). The mortality of an initial variceal hemorrhage has been found to be as high as 30% (The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices 1988). The risk of variceal hemorrhage is increased in large varices and in those that demonstrate red wale markings, as well as in patients with high Child’s scores, those with previous episodes of variceal hemorrhage, and in patients who continue to ingest alcohol (The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices 1988). The size of the varix is the single most important predictor of bleeding risk. KeywordsEndoscopic-Management-Varices-Variceal-Hemorrhage
    01/1970: pages 73-90;
  • [Show abstract] [Hide abstract]
    ABSTRACT: A unified design representation can work. This has always been considered impractical due to major problems of run time, space, tool interdependencies, and multiple representations. We have addressed these problems and found them tractable. We present our solutions to these problems, gained through the experience of developing the Droid design system.
    Design Automation, 1989. 26th Conference on; 01/1989